今すぐ寄付してください会員になる

カート (0)

DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか？ or パスワードをお忘れですか？

Not a Member?

アカウントを作成して参加。

Nihonbashi Life Science HUB

2023年8月07日 (月) 午後 1:00 - 2023年8月07日 (月) 午後 5:00

8F, 1-5-5 Nihonbashi-muromachi, Chuo-ku, Tokyo, 103-0022 Japan

DIA Risk Management Plan Forum 2023

概要

This Forum will be conducted in Japanese Language only.

Click Here to View the Program in Japanese

プログラム委員会

Kazuhiko Ishida, MSc, RPh Director, Pharmacovigilance
Astellas Pharma Inc., Japan
Hiroki Nagahama, MS Director, Medical Governance and Risk Management
GlaxoSmithKline K.K., Japan
Aiko Kumano Reviewer, Office of Safety II
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Hideo Nakada, RPh Deputy Associate Manager, Department of Hospital Pharmacy
Keio University, Japan
Kasumi Daidoji, PhD, RPh Associate Director, Clinical Planning & Development Dept., Medical Headquarters
Eisai Company, Ltd., Japan
Tomoko Yamada Director, Safety risk management, Pharmacovigilance
MSD K.K., Japan
Emiko Iida, MPharm
Daiichi Sankyo Co Ltd, Japan
Akiko Nishioka Clinical Project Manager
Novartis Pharma K.K., Japan
Toshifumi Sugizaki Reviewer, Office of New Drug I
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Ayako Kurokawa
MSD K.K., Japan
Shogo Nakamori, MBA, MSc, RPh Senior Vice President & Managing Director, DIA Japan, Korea, and Singapore
DIA, Japan

Digital Learning Catalog

DIA Learning: eLearning Soultions

Download